Trial intelligence / Profile preview

COLCHIDA: Colchicine for Acute Atherothrombotic Stroke

NCT06102720Phase 4Unknown

Start
Jan 2023
Primary completion
Jan 2025
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of colchicine in ischemic stroke. Status: unknown.

02

Drugs

colchicine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT06102720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06102720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call